WOLVERINE ASSET MANAGEMENT LLC - ACORDA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$12,342,000
-51.5%
14,560,000
-44.7%
0.14%
-56.4%
Q2 2018$25,473,000
+5.6%
26,310,0000.0%0.33%
+5.8%
Q1 2018$24,111,000
+79.3%
26,310,000
+66.4%
0.31%
+129.4%
Q4 2017$13,449,000
-49.6%
15,810,000
-46.5%
0.14%
-53.9%
Q3 2017$26,667,000
+5.2%
29,555,0000.0%0.30%
-8.4%
Q2 2017$25,339,000
+0.7%
29,555,000
+1.5%
0.32%
-17.4%
Q1 2017$25,159,000
+53.7%
29,123,000
+36.0%
0.39%
+84.0%
Q4 2016$16,369,000
-23.1%
21,416,000
-17.7%
0.21%
-33.3%
Q3 2016$21,282,000
-22.1%
26,012,000
-16.4%
0.32%
-23.4%
Q2 2016$27,324,000
+5.0%
31,121,000
+6.9%
0.42%
-43.9%
Q1 2016$26,035,000
-7.8%
29,121,000
+19.0%
0.74%
+21.7%
Q4 2015$28,246,000
+92.3%
24,471,000
+52.3%
0.61%
+75.2%
Q3 2015$14,688,000
+8.3%
16,071,000
+19.7%
0.35%
+12.7%
Q2 2015$13,568,000
+79.0%
13,421,000
+80.9%
0.31%
+104.0%
Q1 2015$7,580,000
-11.3%
7,421,0000.0%0.15%
-9.0%
Q4 2014$8,543,000
+10.7%
7,421,0000.0%0.17%
+3.1%
Q3 2014$7,714,0007,421,0000.16%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Context Capital Management, LLC 3,586,000$3,237,0002.17%
Telemetry Investments, L.L.C. 4,000,000$3,610,0001.29%
Castle Creek Arbitrage, LLC 6,000,000$5,419,0000.54%
Man Investments (CH) AG 600,000$542,0000.46%
SSI INVESTMENT MANAGEMENT LLC 5,683,000$5,129,0000.44%
CANYON CAPITAL ADVISORS LLC 29,000,000$26,173,0000.39%
PFM Health Sciences, LP 21,362,000$19,386,0000.38%
IRON Financial LLC 500,000$454,0000.35%
Partner Investment Management, L.P. 373,000$338,0000.32%
WOLVERINE ASSET MANAGEMENT LLC 29,555,000$26,667,0000.30%
View complete list of ACORDA THERAPEUTICS INC shareholders